“InThera will provide the next-generation VLP-based vaccines and wish to resolve the unmet medical needs against emerging viral infections”

01Certification of R&D Center

02Received Investment from Venture Capital

03Certification of Venture Business Entity

05Received Follow-Up Investment from Accelerator

08Received Grants of IP-Nare Program

06Received Grants of TIPS Program
(Accelerator : Bluepoint Partners)

09Received Grants from Korea Institute of Start-up and
Entrepreneurship Development (KISED)

10Received Grants from MSS for R&D Center Establishment

인테라